Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Myat Min Han"'
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 43-47 (2022)
Acalabrutinib, a second-generation and more selective Bruton's tyrosine kinase inhibitor, was developed to potentiate efficacy while minimizing ibrutinib-associated side effects. We undertook a systematic review and meta-analysis of randomized clinic
Externí odkaz:
https://doaj.org/article/c0220c93af63480281ddf320b0d8004f
Publikováno v:
Journal of Immunotherapy and Precision Oncology. 5:43-47
Acalabrutinib, a second-generation and more selective Bruton's tyrosine kinase inhibitor, was developed to potentiate efficacy while minimizing ibrutinib-associated side effects. We undertook a systematic review and meta-analysis of randomized clinic
Autor:
Kyaw Zin Thein, Thura Win Htut, Myat Min Han, Yin Mon Myat, Myint Aung Win, Ei Moe Phyu, Thein H. Oo
Publikováno v:
Blood. 140:10887-10888
Autor:
Kyaw Zin Thein, Thura Win Htut, Myat Min Han, Yin Mon Myat, Myint Aung Win, Ei Moe Phyu, Thein H. Oo
Publikováno v:
Blood. 140:7997-7998
Autor:
Thura Win Htut, Somedeb Ball, Myat Min Han, Fred Hardwicke, Yin Mon Myat, Kyaw Zin Thein, Sriman Swarup, Anita Sultan, Lukman Aderoju Tijani
Publikováno v:
Journal of Clinical Oncology. 38:12076-12076
12076 Background: Ovarian cancer (OC) is a leading cause of death from gynecologic cancers in women worldwide. Poly adenosine diphosphate ribose polymerase (PARP) inhibitors prevent the repair of single-strand breaks and generate double-strand breaks
Autor:
Ei Moe Phyu, Anita Sultan, Thura Win Htut, Sriman Swarup, Nyein Htway Yu, Myat Min Han, Bradley J. Grant, Kyaw Zin Thein, Nimesh Adhikari, Myint Aung Win, Nicholas D'Cunha, Yin Mon Myat, Chandler Graf, Donald P. Quick
Publikováno v:
Blood. 134:5877-5877
Introduction: Chronic lymphocytic leukemia is the most prevalent adult leukemia in western countries. Phosphatidylinositol 3-kinase (PI3K) is a kinase protein involved in downstream signaling for the B-cell receptor signaling pathway and has been sho
Autor:
Thura Win Htut, Somedeb Ball, Myat Min Han, Ei Moe Phyu, Myint Aung Win, Anita Sultan, Donald P. Quick, Nicholas D'Cunha, Lukman Tijani, Kyaw Zin Thein, Ramesh Kumar Pandey, Aung M. Tun, Sriman Swarup, Fred Hardwicke
Publikováno v:
Blood. 134:3158-3158
Introduction: Management of newly diagnosed multiple myeloma (NDMM), which accounts for 1% of all cancers, is an area in dire need of therapeutic innovation. In recent years, the introduction of novel agents is one of the major advances in the manage
Autor:
Fred Hardwicke, Lukman Tijani, Sriman Swarup, Thura Win Htut, Nicholas D'Cunha, Pwint Phyu Hlaing, Kyaw Zin Thein, Myat Min Han, Yin Mon Myat, Khaing Khaing Htwe, Anita Sultan, Akshar Dash, Sariya Wongsaengsak, Donald P. Quick
Publikováno v:
Blood. 134:2200-2200
Introduction: Bruton's tyrosine kinase (BTK) is a kinase involved in cellular signaling downstream of the B cell receptor and is involved in B-cell survival and proliferation. Hence, BTK inhibitors have become an attractive therapeutic target for a m
Autor:
Ei Moe Phyu, Kyaw Zin Thein, Lukman Tijani, Yin Mon Myat, Donald P. Quick, Myint Aung Win, Nicholas D'Cunha, Sriman Swarup, Nimesh Adhikari, Anita Sultan, Thura Win Htut, Akshar Dash, Myat Min Han, Sanjay Awasthi
Publikováno v:
Blood. 134:1873-1873
Introduction: Multiple myeloma, which accounts for 1% of all cancers, is a hematologic cancer in which clonal plasma-cell proliferation leads to complications and death. Over the recent years, it has shown that the introduction of novel agents, inclu
Autor:
Ye Aung, Thura Win Htut, Fred Hardwicke, Sriman Swarup, Nicholas D'Cunha, Nimesh Adhikari, Kyaw Zin Thein, Pwint Phyu Hlaing, Lukman Tijani, Yin Mon Myat, Donald P. Quick, Anita Sultan, Myat Min Han, Upama Sharma
Publikováno v:
Blood. 134:5479-5479
Introduction: The B-cell receptor signaling pathway involves in the pathogenesis of chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL/ SLL), the most common adult lymphoproliferative disorder in western countries. Ibrutinib, a novel Bruto